GALMED PHARMACEUTICALS LTD. Increase (Decrease) in Other Accounts Payable
GALMED PHARMACEUTICALS LTD. (GLMD) reported Increase (Decrease) in Other Accounts Payable of -$656.00 thousand for the 6-month period ending 2026-06-30, per its 6-K filed 2026-09-02.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherAccountsPayable · last filed 2026-09-02
- GALMED PHARMACEUTICALS LTD. increase (decrease) in other accounts payable for the quarter ending 2025-12-31 was $44.00K.
- GALMED PHARMACEUTICALS LTD. increase (decrease) in other accounts payable for the quarter ending 2025-09-30 was -$254.00K, a 130.94% decline year-over-year.
- GALMED PHARMACEUTICALS LTD. increase (decrease) in other accounts payable for the quarter ending 2024-12-31 was -$307.00K.
- GALMED PHARMACEUTICALS LTD. increase (decrease) in other accounts payable for the quarter ending 2024-09-30 was $821.00K.
| Period end | Increase (Decrease) in Other Accounts Payable 3 month | Increase (Decrease) in Other Accounts Payable 6 month | Increase (Decrease) in Other Accounts Payable 9 month | Increase (Decrease) in Other Accounts Payable 12 month | Increase (Decrease) in Other Accounts Payable 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | -$656.00K 6-K · filed 2026-09-02 | ||||
| 2025-12-31 | $44.00K derived: 20-F 12 month − 6-K 9 month · filed 2026-03-31 | -$210.00K derived: sum of 2 quarters · filed 2026-03-31 | -$23.00K 20-F · filed 2026-03-31 | ||
| 2025-09-30 | -$254.00K derived: 6-K 9 month − 6-K 6 month · filed 2025-11-26 | -$67.00K 6-K · filed 2025-11-26 | |||
| 2025-06-30 | $187.00K 6-K · filed 2026-09-02 | ||||
| 2024-12-31 | -$307.00K derived: 20-F 12 month − 6-K 9 month · filed 2026-03-31 | $514.00K derived: sum of 2 quarters · filed 2026-03-31 | $35.00K 20-F · filed 2026-03-31 | ||
| 2024-09-30 | $821.00K derived: 6-K 9 month − 6-K 6 month · filed 2025-11-26 | $342.00K 6-K · filed 2025-11-26 | |||
| 2024-06-30 | -$479.00K 6-K · filed 2025-08-28 | ||||
| 2023-12-31 | $468.00K 20-F · filed 2026-03-31 | ||||
| 2023-06-30 | $102.00K 6-K · filed 2024-08-28 | ||||
| 2022-12-31 | -$440.00K 20-F · filed 2025-04-02 | ||||
| 2022-06-30 | -$330.00K 6-K · filed 2023-08-09 | ||||
| 2021-12-31 | $38.00K 20-F · filed 2024-04-04 | ||||
| 2021-06-30 | $412.00K 6-K · filed 2022-08-04 | ||||
| 2020-12-31 | $8.00K 20-F · filed 2023-03-29 | $39.00K 20-F · filed 2021-03-18 | |||
| 2020-06-30 | -$141.00K 6-K · filed 2021-08-05 | ||||
| 2019-12-31 | -$144.00K 20-F · filed 2022-05-02 | -$141.00K 20-F · filed 2020-03-12 | |||
| 2019-06-30 | -$349.00K 6-K · filed 2020-08-06 | ||||
| 2018-12-31 | -$142.00K 20-F · filed 2021-03-18 | ||||
| 2018-06-30 | $424.00K 6-K · filed 2019-08-05 | ||||
| 2017-12-31 | $671.00K 20-F · filed 2020-03-12 | ||||
| 2017-06-30 | -$178.00K 6-K · filed 2018-08-02 | ||||
| 2016-12-31 | $81.00K 20-F · filed 2019-03-13 | ||||
| 2016-06-30 | $106.00K 6-K · filed 2017-07-31 | ||||
| 2015-12-31 | $39.00K 20-F · filed 2018-03-13 | ||||
| 2015-06-30 | $29.00K 6-K · filed 2017-06-23 | ||||
| 2014-12-31 | -$91.00K 20-F · filed 2017-03-23 | ||||
| 2013-12-31 | $228.00K 20-F · filed 2016-03-22 | ||||
| 2012-12-31 | -$103.00K 20-F · filed 2015-03-31 |